Reply To: Mounting Evidence Indicates That Escalating Doses of Allopurinol Are Unnecessary for Cardiovascular Protection
Arthritis and Rheumatology - United Kingdom
doi 10.1002/art.40549
Full Text
Open PDFAbstract
Available in full text
Date
August 23, 2018
Authors
Publisher
Wiley